Home News Cignpost Diagnostics partners with American firm LumiraDX to deliver gold standard Covid-19 test results within 20 minutes
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Cignpost Diagnostics partners with American firm LumiraDX to deliver gold standard Covid-19 test results within 20 minutes

by uma


Leading health and diagnostic company, Cignpost Diagnostics, has signed a partnership with LumiraDX. The deal will see LumiraDX’s rapid-result testing technology used by Cignpost for COVID testing across its corporate client base, specifically those in the elite sport and film and TV production sectors.

The collaboration will further bolster Cignpost’s rapid testing capabilities for both rapid antigen and gold-standard PCR methodologies. The LumiraDX SARS-CoV-2 RNA STAR Complete utilises a single-step method for RT-PCR instruments with results available in 20 minutes. The LumiraDX SARS-CoV-2 Antigen Test detects nucleocapsid protein from a nasal swab and presents results in under 12 minutes. The test is one of the fastest and most sensitive antigen tests that are commercially available and has achieved US Food and Drug Administration (FDA) Emergency Use Authorization and CE Marking.

During the pandemic, Cignpost has advised and provided its cutting-edge diagnostic services to organisations across a range of sectors, including elite sports, film and TV production, defence, and financial services. Cignpost’s consumer division, ExpressTest, with 37 testing centres across the UK is the country’s largest Covid test provider.

Nick Markham, Co-founder, Cignpost Diagnostics, said, “Cignpost has a reputation for providing consumers with best-in-class testing resources and this partnership with LumiraDX only elevates the standard of our offering. We are committed to help power the economy’s recovery through the provision of high-quality testing services, to ensure businesses protect their employees’ health and maintain productivity. This collaboration will also open up LumiraDX’ broad diagnostics solutions and allow Cignpost to offer comprehensive health and wellbeing solutions to both its consumer and corporate clientele.”

LumiraDX said, “We are thrilled to be working with Cignpost Diagnostics and be a part of their cutting-edge testing offerings which have been utilised by some of the biggest names in the sport and entertainment industry. Cignpost has done an incredible job in establishing stringent testing protocols for clients, helping organisations maintain business continuity. Our Covid-19 testing options which combine speed with accuracy are a natural fit with the services that Cignpost already offers, and we look forward to a long and fruitful association.”


You may also like